The four-formula line is Olly’s second retailer-exclusive launch this year, following the launch of a probiotic range in April.

A randomized, double-blind, placebo-controlled trial in reproductive-age women found that 8 weeks of standardized shatavari extract supplementation was associated with improvements in sexual function, vaginal moisture, fatigue, and sleep disturbance.

Why responsible innovation means asking whether yesterday's formulations still reflect today's best science—not just launching the next new ingredient.

Women are the predominant users of these drugs, and the authors say guidance has not kept pace, with nutrient gaps and supplement support also in focus.

A new gummy portfolio from ingredient and delivery-format supplier SIRIO Europe illustrates how quickly creatine is being repositioned for general wellness consumers.

The ingredient manufacturer's ingredients now appear in a vaginal microbiome capsule and an allergy oral strip, signaling broader category use for pro- and postbiotics.

In the ninth episode, Nicholas and Lana unpack several longevity launches making waves, and why regulatory clearance, novelty, and clinical data are 3 separate things brands shouldn't blur together.

The company's newest chewable concepts pair postbiotics with biotin and vitamin D3 to support skin, hair, and immune health.